Naing A, Meric-Bernstam F, Stephen B, et al. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J ImmunoTher Cancer 2020;8:e000347. doi: 10.1136/jitc-2019-000347
In the article titled 'Phase 2 study of pembrolizumab in patients with advanced rare cancers', the author name Abulrahman Abonofal is spelt incorrectly. The correct spelling is Abdulrahman Abonofal.